Helsinn Grants Specialised Therapeutics Australia (STA) Rights to Anamorelin

22 October 2012

Helsinn Group, Switzerland announces a license agreement for Netupitant

25 September 2012

Helsinn grants to Dara exclusive u.s. commercial rights to Gelclair®

25 September 2012

Thorne Research, inc. and Helsinn Healthcare SA, announce Oncoqol™

25 September 2012

Cerbios Pharma and XSpray agree to establish a long-term partnership on the use of XSpray’s RightSizeTM technology

31 August 2012

Helsinn partners with the European school of oncology (ESO)

17 July 2012

Lipidor and Cerbios-Pharma have signed an agreement for the co- development of an innovative topical delivery system

13 June 2012

Cerbios appoints Andrea Tam as Director of Commercial Business Development

22 May 2012

Voluntary Climate Protection

16 March 2012